Effects lovastatin diabetic patients chlorpropamide Patients non-insulin dependent diabetes NIDDM risk atherosclerotic cardiovascular disease nondiabetic subjects patients hypercholesterolemia NIDDM chlorpropamide lovastatin mg b.i.d weeks low-density lipoprotein cholesterol total cholesterol Lovastatin levels period coenzyme reductase inhibitory activity similar nondiabetic patients Lovastatin chlorpropamide kinetics glycemic profiles patient elevation serum transaminases creatinine phosphokinase patient laboratory clinical drug-related adverse experience study Lovastatin effective low-density lipoprotein cholesterol patients NIDDM nondiabetic subjects Diabetic control unaltered evidence alteration lovastatin blood levels 